| Financial Year |
March 31 2023 |
| Monetary Funds |
368,609,861.08 |
| Held-for-trading Financial Assets |
11,238,139.53 |
| Notes Receivable |
-- |
| Accounts Receivable |
110,485,506.80 |
| Advances to Suppliers |
9,092,128.96 |
| Other Receivables |
51,191,222.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
47,482,045.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
978,635.08 |
| Total Current Assets |
599,077,539.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
5,917,954.56 |
| Fixed Assetes |
232,029,826.06 |
| Under-construction Projects |
1,028,553.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
161,057,493.73 |
| R&D expenses |
-- |
| Goodwill |
6,957,785.83 |
| Long-Term Deferred and Prepaid Expenses |
14,579,160.49 |
| Deferred Income Tax Assets |
25,588,332.36 |
| Other Non-Current Assets |
26,545,305.49 |
| Sub-Total of Non-Current Assets |
592,170,353.16 |
| Total Assets |
1,191,247,892.87 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
21,133,428.53 |
| Accounts Received In Advance |
347,865.12 |
| Employee Compensation Payable |
2,155,917.13 |
| Taxes Payable |
67,852,259.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
23,485,739.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
114,975,210.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
10,763,617.86 |
| Deferred Income Tax Liabilities |
19,955,879.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,719,496.89 |
| Total Liabilities |
145,694,706.89 |
| Paid-In Capital(Or Share Stock) |
274,000,000.00 |
| Capital Surplus |
579,782,363.29 |
| Surplus Reserve |
96,726,055.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-33,910,330.08 |
| Minority Stockholder's Interest |
38,335,653.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,007,217,532.17 |
| Owner's Equity（Stockholder's Equity） |
1,045,553,185.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,191,247,892.87 |
